Abdominopelvic Fascial Release for Post-Cesarean Menstrual Pain and Scar Mobility
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-35
SponsorCairo University
About this trial
The goal of this randomized controlled clinical trial is to determine whether adding abdominopelvic fascial release to a standardized stretching exercise program is more effective than stretching exercises alone in reducing menstrual pain in women following cesarean section. The study will enroll women aged 20 to 35 years with moderate to severe dysmenorrhea after cesarean delivery. Researchers will compare the effects of abdominopelvic fascial release combined with stretching exercises with stretching exercises alone on menstrual pain and scar mobility. Participants will be randomly assigned to one of two treatment groups, undergo assessments before and after the intervention period, and receive the assigned treatment according to the study protocol.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Females aged 20 to 35 years.
History of at least one cesarean section.
Moderate to severe primary or secondary dysmenorrhea following cesarean section.
Regular menstrual cycles (21-35 days).
Disqualifiers
Pregnancy or planned pregnancy during the study period.
Previous abdominal or pelvic surgery other than cesarean section.
Endometriosis, adenomyosis, uterine fibroids requiring treatment, or other diagnosed gynecological disorders associated with pelvic pain.
Active pelvic inflammatory disease or genitourinary infection.
Trial design
Design model
Parallel
Treatments tested in this trial
Abdominopelvic fascial Release
Other interventionAbdominopelvic fascial release is a manual therapy intervention designed to restore mobility of the abdominal and pelvic fascial tissues by applying sustained, low-load pressure to fascial restrictions. The treatment targets the cesarean scar, abdominal fascia, diaphragm, and psoas muscle to improve fascial mobility, reduce tissue restrictions, alleviate pain, and enhance tissue function. The intervention will be administered for 30 minutes per session, twice weekly for 2 weeks by a licensed physiotherapist.
Treatment groups
58 Participants
are divided into 2 treatment groupsGroup A: Abdominopelvic Fascial Release + Stretching ExercisesExperimental treatment 1 intervention
Group B: Stretching Exercises AloneActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Change in Menstrual Pain Intensity
Menstrual pain intensity will be assessed using the Visual Analog Scale (VAS), a validated 10-cm scale ranging from 0 (no pain) to 10 (worst imaginable pain). The primary outcome is the change in VAS score from baseline to the end of the intervention period.
Time frame
Baseline and immediately after completion of the 4-week intervention period.Secondary outcomes
1
Change in Cesarean Scar Mobility
Scar mobility will be assessed using an adheremeter. Greater mobility values indicate improved scar tissue mobility.
Time frame
Baseline and immediately after completion of the 4-week intervention period.2
Change in Dysmenorrhea Severity
Dysmenorrhea severity will be assessed using the Working ability, Location, Intensity, Days of pain, and Dysmenorrhea (WaLIDD) Score. The total score ranges from 0 to 12, with higher scores indicating more severe dysmenorrhea.
Time frame
Baseline and immediately after completion of the 4-week intervention period.3
Change in Pressure Pain Threshold
Pressure pain threshold will be assessed using a pressure algometer over the abdominal region.
Time frame
Baseline and immediately after completion of the 4-week intervention period.Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Cairo University
Lead sponsor
Horus University
Sponsor institution
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: